Complete or incomplete revascularization in patients with left main culprit lesion acute myocardial infarction with

Sun Oh Kim1, Hong-Ju Kim1, Jong-Il Park1

  • 1Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea.

PubMed

Insights

For acute myocardial infarction (AMI) involving the left main (LM) artery with multivessel disease, complete revascularization showed no significant clinical outcome benefit over incomplete revascularization at one year. This finding applies to patients undergoing percutaneous coronary intervention.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Complete revascularization improves outcomes in acute myocardial infarction (AMI) with multivessel disease.
  • Evidence is limited regarding the benefit of complete revascularization in left main (LM) culprit lesion AMI with multivessel disease.

Purpose of the Study:

  • To compare the clinical outcomes of complete versus incomplete revascularization in patients with LM culprit lesion AMI and multivessel disease.

Main Methods:

  • Retrospective review of 16,831 patients from the Korea Acute Myocardial Infarction Registry (July 2016-June 2020).
  • 399 patients with LM culprit lesion AMI treated with percutaneous coronary intervention were analyzed.
  • Propensity score matching (PSM) was used to compare outcomes between complete (n=295) and incomplete (n=104) revascularization groups.
  • The primary endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.

Main Results:

  • After PSM, no significant difference in MACCE at 1 year was observed between complete and incomplete revascularization groups (12.1% vs. 15.2%; p=0.524).
  • Individual components of MACCE and rates of major bleeding were also similar between the groups.

Conclusions:

  • Complete revascularization does not offer a significant clinical outcome advantage over incomplete revascularization in LM culprit lesion AMI with multivessel disease.
  • Percutaneous coronary intervention strategies for this specific patient group require further investigation.
Abstract